Calyculin A stimulates the expression of TNF-α mRNA via phosphorylation of Akt in mouse osteoblastic MC3T3-E1 cells

Molecular and Cellular Endocrinology

Volumn 271, Issue 1-2, 2007, Pages 38-44

  Qiu, Lihong ^a,b   Yoshida, Kaya ^a   Amorim, Bruna Rabelo ^a   Okamura, Hirohiko ^a   Haneji, Tatsuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Calyculin A; NF B; Osteoblasts; Protein phosphatase; TNF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BAY11 7085; CALYCULIN A; I KAPPA B; MESSENGER RNA; PHOSPHATASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ANIMALS; ENZYME INHIBITORS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXAZOLES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249007177     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.03.005     Document Type: Article

References (40)

1. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R.J., Reese C.B., and Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7 (1997) 261-269
2. Andjelkovic M., Jakubowicz T., Cron P., Ming X., Han J., and Hemmings B.A. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5699-5704
3. Bhat N.R., Zhang P., Lee J.C., and Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18 (1998) 1633-1641
4. Boehringer N., Hagens G., Songeon F., Isler P., and Nicod L.P. Differential regulation of tumor necrosing factor-α (TNF-α) and interleukin-10 (IL-10) secretion by protein kinase and phosphatase inhibitors in human alveolar macrophages. Eur. Cytokine Netw. 10 (1999) 211-217
5. Ceulemans H., and Bollen M. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84 (2004) 1-39
6. 2 activity in Swiss 3T3 cells. J. Biol. Chem. 270 (1995) 25352-25355
7. i proteins and Src tyrosine kinase in TNF-α production induced by lipopolysaccharide, group B streptococci and Staphylococcus aureus. Cytokine 22 (2003) 126-133
8. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van-Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
9. Fujita M., Goto K., Yoshida K., Okamura H., Morimoto H., Kito S., Fukuda J., and Haneji T. Okadaic acid stimulates expression of Fas receptor and Fas ligand by activation of nuclear factor kappa-B in human oral squamous carcinoma cells. Oral Oncol. 40 (2004) 199-206
10. Gilbert L., He X., Farmed P., Boden S., Kozlowski M., Rubin J., and Nanes M.S. Inhibition of osteoblast differentiation by tumor necrosis factor-α. Endocrinology 141 (2000) 3956-3964
11. 2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-κB-p300 pathway independent of peroxisome proliferator-activated receptor γ. J. Immunol. 173 (2004) 5196-5208
12. Grossman B.J., Shanley T.P., Denenberg A.G., Zhao B., and Wong H.R. Phosphatase inhibition leads to activation of IκB kinase in murine macrophages. Biochem. Biophys. Res. Commun. 297 (2002) 1264-1269
13. Haneji T. Association of protein phosphatase 1 delta with nucleolin in osteoblastic cells and cleavage of nucleolin in apoptosis-induced osteoblastic cells. Acta Histochem. Cytochem. 38 (2005) 1-8
14. Harada S., and Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 423 (2003) 349-355
15. Henry J.R., Rupert K.C., Dodd J.H., Turchi I.J., Wadsworth S.A., Cavender D.E., Schafer P.H., and Siekieka J.J. Potent inhibitors of the MAP kinase p38. Bioorg. Med. Chem. Lett. 8 (1998) 3335-3340
16. Honkanen R.E., and Golden T. Regulators of serine/threonine protein phosphatases at the dawn of a clinical era? Curr. Med. Chem. 9 (2002) 2055-2075
17. Inoki K., Li Y., Zhu T.Q., Wu J., and Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4 (2002) 648-657
18. 3 receptor suppresses lipopolysaccharide-induced TNF-α production through inhibition of PI3-kinase/Akt and NF-κB activation in murine BV2 microglial cells. Neurosci. Lett. 396 (2006) 1-6
19. Martelli A.M., Faenza I., Billi A.M., Manzoli L., Evangelisti C., Falà F., and Cocco L. Intranuclear 3′-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis?. Cell Signal 18 (2006) 1101-1107
20. Morimoto H., Okamura H., Yoshida K., Kitamura S., and Haneji T. Okadaic acid induces apoptosis through double-stranded RNA-dependent protein kinase/eukaryotic initiation factor-2α pathway in human osteoblastic MG63 cells. J. Biochem. 136 (2004) 433-438
21. Morimoto Y., Ohba T., Kobayashi S., and Haneji T. The protein phosphatase inhibitors okadaic acid and calyculin A induce apoptosis in human osteoblastic cells. Exp. Cell Res. 230 (1997) 181-186
22. Morisco C., Condorelli G., Trimarco V., Bellis A., Marrone C., Condorelli G., Sadoshima J., and Trimarco B. Akt mediates the cross-talk between β-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ. Res. 96 (2005) 180-188
23. Mundy G.R., Boyce B., Hughes D., Wright K., Bonewald L., Dallas S., Harris S., Ghosh-choudhury N., Chen D., Dunstan C., Izbicka E., and Yoneda T. The effects of cytokines and growth factors on osteoblastic cells. Bone 17 (1995) 71s-75s
24. Nanes M.S. Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology. Gene 321 (2003) 1-15
25. Natarajan K., Singh S., Burke T.R., Grunberger D., and Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9090-9095
26. Okamura H., Yoshida K., Morimoto H., and Haneji T. PTEN expression elicited by EGR-1 transcription factor in calyculin A-induced apoptotic cells. J. Cell. Biochem. 94 (2005) 117-125
27. Okamura H., Yoshida K., Sasaki E., Qiu L., Amorim B.R., Morimoto H., and Haneji T. Expression of PTEN and Akt phosphorylation in lipopolysaccharide-treated NIH3T3 cells. Cell Biol. Int. 31 (2007) 119-125
28. Papadakis K.A., and Targan S.R. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 119 (2000) 1148-1157
29. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., and Gerritsen M.E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272 (1997) 21096-21103
30. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., and Jongeneel C.V. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171 (1990) 35-47
31. Shanley T.P., Vasi N., Denenberg A., and Wong H.R. The serine/threonine phosphatase PP2A: endogenous regulator of inflammatory cell signalling. J. Immunol. 166 (2001) 966-972
32. Suganuma M., Fujiki H., Furuya-Suguri H., Yoshizawa S., Yasumoto S., Kato Y., Fusetani N., and Sugimura T. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin. Cancer Res. 50 (1990) 3521-3525
33. Sung S.J., Walters J.A., and Fu S.M. Stimulation of tumor necrosis factor α production in human monocytes by inhibitors of protein phosphatase 1 and 2A. J. Exp. Med. 176 (1992) 897-901
34. Takai S., Tokuda H., Matsushima-Nishiwaki R., Hanai Y., Kato K., and Kozawa O. Phosphatidylinositol 3-kinase/Akt plays a role in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts. J. Cell. Biochem. 98 (2006) 1249-1256
35. Vlahos C.J., Matter W.F., Brown R.F., Traynor-Kaplan A.E., Heyworth P.G., Prossnitz E.R., Ye R.D., Marder P., Schelm J.A., Rothfuss K.J., Serlin B.S., and Simpson P.J. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J. Immunol. 154 (1995) 2413-2422
36. Wera S., and Hemmings B.A. Serine/threonine protein phosphatases. Biochem. J. 311 (1995) 17-29
37. Yoshida K., Okamura H., Amorim B.R., Ozaki A., Tanaka H., Morimoto H., and Haneji T. Double-stranded RNA-dependent protein kinase is required for bone calcification in MC3T3-E1 cells in vitro. Exp. Cell Res. 311 (2005) 117-125
38. Ziegler-Heitbrock H.W.L., Sternsdorf T., Liese J., Belohradsky B., Weber C., Wedel A., Schreck R., Bauerle P., and Strobel M. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J. Immunol. 151 (1993) 6986-6993
39. Ziolkowska M., Kurowska M., Radzikowska A., Luszczykiewicz G., Wiland P., Dziewczopolski W., Filipowicz-Sosnowska A., Pazdur J., Szechinski J., Kowalczewski J., Rell-Bakalarska M., and Maslinski W. High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor α treatment. Arthritis Rheum. 46 (2002) 1744-1753
40. Zou W., Hakim I., Tschoep K., Endres S., and Bar-Shavit Z. Tumor necrosis factor-α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J. Cell. Biochem. 83 (2001) 70-83